Literature DB >> 28706911

Malignant pleural mesothelioma: predictors and staging.

William G Richards1.   

Abstract

Malignant pleural mesothelioma remains a rapidly fatal cancer with few effective therapies. Unusual anatomic features complicate determination of stage and prognosis for individual patients. Validation of staging criteria has been difficult given the rarity of the disease and the fact that only a minority of patients undergo surgical resection with pathological examination of their tumors. Thus, additional heuristic factors and algorithms have been taken into account by clinicians to estimate prognosis and inform discussion of appropriate management strategies or clinical research protocols with patients.

Entities:  

Keywords:  Mesothelioma; prognosis; staging

Year:  2017        PMID: 28706911      PMCID: PMC5497102          DOI: 10.21037/atm.2017.06.26

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  81 in total

1.  Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.

Authors:  R T Heelan; V W Rusch; C B Begg; D M Panicek; J F Caravelli; C Eisen
Journal:  AJR Am J Roentgenol       Date:  1999-04       Impact factor: 3.959

2.  Prognostic value of FDG PET imaging in malignant pleural mesothelioma.

Authors:  F Bénard; D Sterman; R J Smith; L R Kaiser; S M Albelda; A Alavi
Journal:  J Nucl Med       Date:  1999-08       Impact factor: 10.057

3.  Surgical assessment of malignant pleural mesothelioma: have we reached a critical stage?

Authors:  Apostolos Nakas; Edward Black; James Entwisle; Salli Muller; David A Waller
Journal:  Eur J Cardiothorac Surg       Date:  2010-02-06       Impact factor: 4.191

4.  Predictors of long-term survival following radical surgery for malignant pleural mesothelioma.

Authors:  Apostolos Nakas; David Waller
Journal:  Eur J Cardiothorac Surg       Date:  2014-01-30       Impact factor: 4.191

5.  High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.

Authors:  Steven C H Kao; Nick Pavlakis; Rozelle Harvie; Janette L Vardy; Michael J Boyer; Nico van Zandwijk; Stephen J Clarke
Journal:  Clin Cancer Res       Date:  2010-10-18       Impact factor: 12.531

6.  Staging algorithm for diffuse malignant pleural mesothelioma.

Authors:  Marcin Zielinski; Jolanta Hauer; Lukasz Hauer; Juliusz Pankowski; Tomasz Nabialek; Artur Szlubowski
Journal:  Interact Cardiovasc Thorac Surg       Date:  2009-10-20

Review 7.  Making the case for molecular staging of malignant pleural mesothelioma.

Authors:  Raphael Bueno
Journal:  Semin Thorac Cardiovasc Surg       Date:  2009

8.  The proposed new international TNM staging system for malignant pleural mesothelioma: application to imaging.

Authors:  E F Patz; V W Rusch; R Heelan
Journal:  AJR Am J Roentgenol       Date:  1996-02       Impact factor: 3.959

9.  Postmortem findings of malignant pleural mesothelioma: a two-center study of 318 patients.

Authors:  Rhian S Finn; Fraser J H Brims; Arjun Gandhi; Nola Olsen; A William Musk; Nick A Maskell; Y C Gary Lee
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

10.  Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee.

Authors:  Harvey I Pass; Dorothy Giroux; Catherine Kennedy; Enrico Ruffini; Ayten K Cangir; David Rice; Hisao Asamura; David Waller; John Edwards; Walter Weder; Hans Hoffmann; Jan P van Meerbeeck; Valerie W Rusch
Journal:  J Thorac Oncol       Date:  2014-06       Impact factor: 15.609

View more
  3 in total

Review 1.  Carbon Nanotubes and Other Engineered Nanoparticles Induced Pathophysiology on Mesothelial Cells and Mesothelial Membranes.

Authors:  Sotirios I Sinis; Chrissi Hatzoglou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Front Physiol       Date:  2018-03-29       Impact factor: 4.566

2.  Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study.

Authors:  Nobukazu Fujimoto; Morihito Okada; Takashi Kijima; Keisuke Aoe; Terufumi Kato; Kazuhiko Nakagawa; Yuichiro Takeda; Toyoaki Hida; Kuninobu Kanai; Jun Hirano; Yuichiro Ohe
Journal:  JTO Clin Res Rep       Date:  2020-12-29

3.  Does size matter? -a population-based analysis of malignant pleural mesothelioma.

Authors:  Jiaxi He; Songhui Xu; Hui Pan; Shuben Li; Jianxing He
Journal:  Transl Lung Cancer Res       Date:  2020-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.